GW Cancer Center Researcher Receives More than $1.8M for Study on Prostate Cancer Disparities

Dr. Norman Lee posing for a portrait

A team at the George Washington University (GW) was awarded more than $1.8 million from the National Institutes of Health to investigate the mechanisms driving dysregulation splicing factor expression.

Prostate cancer is the most common cancer in men besides skin cancer and develops mainly in older men and is particularly prevalent among African-American men. In addition, African-American prostate cancers express unique mRNA variants not found in European-American counterparts. Previous studies have found that several RNA splicing factors are dysregulated in African-American prostate cancer, and researchers believe this is responsible, in part, for the more aggressive nature of the disease and poorer prognosis in the African-American population.

RNA splicing is the editing of nascent precursor messenger RNA in which exons are joined together to form mature mRNA. The different combinations of exons can lead to proteins of different functions.

“Our findings in this study may explain the observed cancer health disparities in the African-American population relative to other population groups,” said Norman Lee, PhD, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences and principal investigator on the study. “Our goal is to identify the mechanism behind dysregulated splicing and provide a mechanistic framework of population-related differences in alternative RNA splicing.”

The framework, Lee explained, could facilitate future identification of targets of tumor phenotype and disparities in the African-American population.

The grant will fund the study, titled “Consequences and Mechanism of Aberrant Splicing in African American Prostate Cancer Disparities” through February 2022.

Latest News

Julie E. Bauman, MD, MPH, and Sharad Goyal, MD, were among 100 physicians and researchers selected as the 2025 recipients of the Fellow of the American Society of Clinical Oncology (FASCO) designation.
Researchers from the George Washington University School of Medicine and Health Sciences (GW SMHS) publish a new study in Nature Communications identifying a critical protein, And-1, that plays a vital role in repairing DNA damage caused by UVB radiation — the harmful rays from the sun that can…
Community leaders, health professionals, and local residents joined members of the George Washington University (GW) School of Medicine and Health Sciences to celebrate the official ribbon-cutting of the new GW Cancer Prevention and Wellness Center, located on the historic St. Elizabeths campus in…